FDA Orange Book

Is there a generic for Triesence?

Triesence contains triamcinolone acetonide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Triesence (triamcinolone acetonide). The Orange Book shows its last listed patent expires December 17, 2029.

Run it in Rivvi

Map Triesence and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Triesence products in the Orange Book

Triesence products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
injectable, intravitreal40MG/ML (40MG/ML)Marketed (Rx)None0None

NDA 022048, held by HARROW EYE LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Triesence patents

Patents listed for Triesence
PatentExpiresCoversUse codeNDA
8211880March 10, 2029Method of useU-1258022048
8211880March 10, 2029Method of useU-1257022048
8128960December 17, 2029Drug productNone022048

Triesence NDC codes

Questions

Is there a generic for Triesence?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Triesence (triamcinolone acetonide). The Orange Book shows its last listed patent expires December 17, 2029.

What is the generic name for Triesence?

The active ingredient in Triesence is triamcinolone acetonide, per the FDA Orange Book.

When does the Triesence patent expire?

The last patent listed for Triesence in the Orange Book expires December 17, 2029. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Triesence and Triamcinolone Acetonide

Try it on your own data today.

Free to start. Most teams are using it the same day.